| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 28,173 | 29,471 | 23,717 | 24,442 | | Cost of Revenue | 6,179 | 6,276 | 4,858 | 4,196 | | | Gross Profit | 21,994 | 23,195 | 18,859 | 20,246 | | | Operating Expenses | | Research Development | 5,010 | 5,061 | 5,173 | 5,466 | | Selling General and Administrative | 12,902 | 12,520 | 13,361 | 11,685 | | Non Recurring |
-
|
-
|
-
| 4,012 | | Others | 2,489 | 2,535 | 2,646 | 2,377 | | | | Total Operating Expenses |
-
|
-
|
-
| 23,540 | | | | Operating Income or Loss | 1,593 | 3,079 | (2,321) | (3,294) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| 217 | 303 | 649 | | Earnings Before Interest And Taxes | 1,667 | 3,296 | (2,018) | (2,644) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 1,667 | 3,296 | (2,018) | (2,644) | | Income Tax Expense | 896 | 1,602 | (727) | (1,663) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 752 | 1,694 | (1,291) | (981) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 771 | 1,694 | (1,291) | (981) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $771 | $1,694 | ($1,291) | ($981) |
|
0.04% Nasdaq 
0.56%
Income Statement
